By Product
By Application
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oxygen and Aerosol Delivery Devices Market Snapshot
Chapter 4. Global Oxygen and Aerosol Delivery Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers and Challenges
4.3. Trends
4.4. Industry Analysis – Porter’s Five Forces Analysis
4.5. Competitive Landscape & Market Share Analysis
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Type:
5.2.1. Oxygen Masks
5.2.2. Nasal Cannulas/ Nasal Oxygen Catheter
5.2.3. Oxygen Connecting Tube
5.2.4. Venturi Masks
5.2.5. Non-rebreather Masks
5.2.6. Reusable Nebuliser
5.2.7. Disposable Nebuliser
5.2.8. Other Oxygen Delivery Devices
Chapter 6. Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
6.2.1. COPD
6.2.2. Asthma
6.2.3. Cystic Fibrosis
6.2.4. Respiratory Distress Syndrome
6.2.5. Pneumonia
6.2.6. Other Diseases
Chapter 7. Oxygen and Aerosol Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.1.2. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Product, 2019-2031
7.1.3. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by country, 2019-2031
7.1.3.1. US
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.2.2. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.2.3. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2019-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.3.2. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.3.3. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2019-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.4.2. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.4.3. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, (US$ Million) 2019-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.5.2. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.5.3. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2031
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Medline Industries, Inc.
8.2.2. Salter Labs Inc.
8.2.3. Vygon SA
8.2.4. Smiths Medical, Inc.
8.2.5. Medicoplast International GmbH
8.2.6. Purple Surgical
8.2.7. Pennine Healthcare
8.2.8. Besmed Health Business Corp.
8.2.9. Intersurgical Ltd
8.2.10. B. Braun Melsungen AG
8.2.11. ConvaTec Inc.
8.2.12. Flexicare Medical Ltd.
8.2.13. GaleMed Corporation
8.2.14. PARI GmbH
8.2.15. Polymedicure
8.2.16. Teleflex Incorporated
8.2.17. HSINER CO., LTD.
8.2.18. ASID BONZ GmbH
8.2.19. Sumi spó?ka z ograniczon? odpowiedzialno?ci? sp.k.
8.2.20. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.